<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.hcplive.com/view/lessons-from-zeus-on-targeting-inflammation-with-peter-libby-md</loc>
      <lastmod>2026-11-18T14:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:45:00Z</news:publication_date>
        <news:title><![CDATA[Lessons From ZEUS on Targeting Inflammation, With Peter Libby, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/stepwise-chronic-spontaneous-urticaria-management-timothy-craig-do</loc>
      <lastmod>2026-11-18T14:20:53.469Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:20:53.469Z</news:publication_date>
        <news:title><![CDATA[Stepwise Chronic Spontaneous Urticaria Management, With Timothy Craig, DO]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/defining-and-monitoring-long-term-eoe-control</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Defining and Monitoring Long-Term EoE Control]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/setting-expectations-for-long-term-eoe-treatment</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Setting Expectations for Long-Term EoE Treatment]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/renew-blinded-interim-data-show-fvc-trends-lti-03-ipf</loc>
      <lastmod>2026-11-18T12:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T12:00:00Z</news:publication_date>
        <news:title><![CDATA[RENEW: Blinded Interim Data Show FVC Trends With LTI-03 in IPF]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/challenges-clear-peanut-labels-35-percent-infants-maskatia-md</loc>
      <lastmod>2026-11-17T22:00:08.872Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T22:00:08.872Z</news:publication_date>
        <news:title><![CDATA[Challenges Clear Peanut Labels in 35% of Infants: Rani Maskatia, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/top-videos-2026-dermatology-meetings-expert-interviews</loc>
      <lastmod>2026-11-17T21:46:36.836Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T21:46:36.836Z</news:publication_date>
        <news:title><![CDATA[Top Videos From 2026 Dermatology Meetings: 12 Expert Interviews to Watch]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ultra-processed-food-intake-increases-risk-of-hf-in-all-phenotypes</loc>
      <lastmod>2026-11-17T21:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T21:45:00Z</news:publication_date>
        <news:title><![CDATA[Ultra-Processed Food Intake Increases Risk of HF in All Phenotypes]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/inflammation-as-a-treatable-driver-of-atherosclerosis-with-peter-libby-md</loc>
      <lastmod>2026-11-17T19:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T19:45:00Z</news:publication_date>
        <news:title><![CDATA[Inflammation as a Treatable Driver of Atherosclerosis, With Peter Libby, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/upadacitinib-safety-in-real-world-crohn-s-disease-care-with-raja-atreya-md</loc>
      <lastmod>2026-11-17T18:00:19.905Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T18:00:19.905Z</news:publication_date>
        <news:title><![CDATA[Upadacitinib Safety in Real-World Crohn’s Disease Care, With Raja Atreya, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/panadipo-ai-tool-proves-efficacy-of-ai-enabled-cardiography-for-characterizing-eat</loc>
      <lastmod>2026-11-17T17:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T17:45:00Z</news:publication_date>
        <news:title><![CDATA[PanAdipo AI Tool Proves Efficacy of AI-Enabled Cardiography for Characterizing EAT]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/upadacitinib-response-within-days-in-crohn-s-disease-with-raja-atreya-md</loc>
      <lastmod>2026-11-17T17:00:19.905Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T17:00:19.905Z</news:publication_date>
        <news:title><![CDATA[Upadacitinib Response Within Days in Crohn’s Disease, With Raja Atreya, MD]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/dont-miss-a-beat-how-prediction-markets-could-threaten-clinical-trial-integrity</loc>
      <lastmod>2026-11-17T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Don't Miss a Beat: How Prediction Markets Could Threaten Clinical Trial Integrity]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/asundexian-s-fda-approval-opens-doors-for-future-antithrombotic-therapies</loc>
      <lastmod>2026-11-16T22:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T22:00:00Z</news:publication_date>
        <news:title><![CDATA[Asundexian’s FDA Approval Opens Doors for Future Antithrombotic Therapies]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-optimal-diabetes-survodutide-and-orforglipron-at-aha-2026</loc>
      <lastmod>2026-11-16T19:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: OPTIMAL-DIABETES, Survodutide, and Orforglipron at AHA 2026]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-tubeless-mobi-clearance-cgm-choice-and-eversense-freedom</loc>
      <lastmod>2026-11-16T18:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: Tubeless Mobi Clearance, CGM Choice, and Eversense Freedom]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/microbiome-therapies-show-potential-in-hepatic-encephalopathy</loc>
      <lastmod>2026-11-16T16:56:41.331Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T16:56:41.331Z</news:publication_date>
        <news:title><![CDATA[Microbiome Therapies Show Potential in Hepatic Encephalopathy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/treatment-gaps-persist-in-hepatic-encephalopathy-despite-standard-care</loc>
      <lastmod>2026-11-16T16:56:41.331Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T16:56:41.331Z</news:publication_date>
        <news:title><![CDATA[Treatment Gaps Persist in Hepatic Encephalopathy Despite Standard Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/remibrutinib-cindu-responses-week-52-giselle-mosnaim-md</loc>
      <lastmod>2026-11-16T16:43:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>HCPLive</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T16:43:00Z</news:publication_date>
        <news:title><![CDATA[Remibrutinib Sustains CIndU Responses at Week 52, with Giselle Mosnaim, MD]]></news:title>
      </news:news>
	</url></urlset>